Related Experiment Videos
Dobutamine increases diaphragmatic contractility in dogs.
1Department of Anesthesiology and Critical Care Medicine, School of Medicine, Tokyo Medical and Dental University, Japan.
Summary
Dobutamine enhances canine diaphragmatic contractility by increasing transdiaphragmatic pressure (Pdi). This effect, linked to calcium influx, was blocked by nicardipine, suggesting a novel therapeutic pathway for respiratory muscle weakness.
Area of Science:
- Physiology
- Pharmacology
Background:
- Diaphragmatic contractility is crucial for respiration.
- Understanding agents that modulate respiratory muscle function is vital for clinical applications.
Purpose of the Study:
- To investigate the effects of dobutamine on diaphragmatic contractility in a canine model.
- To explore the potential mechanisms underlying dobutamine's action on the diaphragm.
Main Methods:
- Electrophrenic stimulation was used to assess diaphragmatic contractility via transdiaphragmatic pressure (Pdi) in anesthetized, mechanically ventilated dogs.
- Phrenic nerves were stimulated at varying frequencies (10-100 Hz).
- Diaphragmatic electrical activity (Edi) and the effects of dobutamine, nicardipine, and prostaglandin E1 were measured.
Main Results:
- Dobutamine significantly increased Pdi by 15% at 20 Hz and 13% at 100 Hz stimulation (P < 0.01).
- Dobutamine did not alter diaphragmatic electrical activity (Edi).
- The enhancement of Pdi by dobutamine was abolished by nicardipine, a calcium channel blocker, but unaffected by prostaglandin E1.
Conclusions:
- Dobutamine exerts a direct stimulating effect on canine diaphragmatic contractility.
- This action appears to be mediated by an increase in intracellular calcium influx.
- Dobutamine may represent a potential therapeutic agent for conditions involving diaphragmatic dysfunction.